Amplius Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,419
Closed -$260K 181
2025
Q2
$260K Buy
2,419
+38
+2% +$3.85K 0.02% 173
2025
Q1
$240K Buy
2,381
+124
+5% +$12.5K 0.03% 162
2024
Q4
$202K Buy
+2,257
New +$199K 0.02% 171
2022
Q1
Sell
-1,902
Closed -$80K 262
2021
Q4
$80K Buy
+1,902
New +$79.9K 0.01% 269

Other funds holding BSX

Amplius Wealth Advisors's BSX Position: Q3 2025 in Review

Amplius Wealth Advisors sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,419 shares — an estimated $260K sold.

Amplius Wealth Advisors first reported a position in BSX in Q4 2021 and held it in 4 quarters. The position peaked at $260K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Amplius Wealth Advisors reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Amplius Wealth Advisors sold 2,419 Boston Scientific shares in Q3 2025, an estimated $260K.
  • Amplius Wealth Advisors first reported a position in Boston Scientific in Q4 2021 and held it in 4 quarters.
  • Amplius Wealth Advisors's Boston Scientific position peaked at $260K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Amplius Wealth Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.